The highest sensitivity to your greatest needs²

Discovery IQ Gen 2 reinforces what the highest sensitivity can do for your image quality. Built with a combination of the highest NEMA sensitivity², the highest clinical NECR² and outstanding field-of-view coverage, this PET/CT system has exceptional small lesion detectability. Amongst these industry-leading capabilities, Discovery IQ Gen 2 also features Smart MAR, which helps reduce metal artifacts, providing significant reduction of streaks and shadows to save time from correcting images. It is imaging in the highest sense, using the lowest amount of dose possible and faster acquisition times to acquire high-clarity images like no other PET/CT system.

Clear the way for clear images

Respiratory motion negatively affects about half of all PET/CT procedures. Current gating solutions are cumbersome and take too long to set up, which puts you in the difficult position of having to pick and choose which situations to use it in. As a result, only a small percentage of overall procedures affected by motion receive the benefits of motion correction. However, now with MotionFree, Discovery IQ Gen 2 assures that every patient gets the benefit of reduced motion during their exams for exceptionally clear images.

MotionFree is the first-ever digital respiratory motion management solution that completely eliminates the need for a gating device. It continually monitors respiratory motion in every PET/CT procedure, automatically modifies the scan and then integrates what it learns into the final image in real time. MotionFree is the new standard for PET imaging and an essential tool for better outcomes.

Since its introduction, Q.Clear has delivered fast and efficient quantitation readings for confident diagnosis and precise treatment response assessment by providing up to two times improvement in both PET quantitation accuracy (SUV_mean) and image quality (SNR). Now, improvements in the Q.Clear algorithm are further enhancing the resolution of brain images in vertical/coronal planes.

Detection at the speed of light

Discovery IQ Gen 2 comes with the LightBurst PET Detector that reduces scan times and dose amounts in half⁶. Combined with the next-generation improvements in sensitivity, motion correction and quantitation, you can expect increases in the image clarity, the speed that you acquire images and the confidence you have in seeing smaller lesions. We paired this innovative detector technology with the Optima™ CT540, which has the equivalent speed of a 50-slice CT with IQE 1.75 pitch booster⁷ to meet your imaging needs. The LightBurst PET Detector is compatible with advanced digital solutions designed to connect machines, people and data through a portfolio of healthcare analytics applications.

Healthcare providers, especially in emerging and growing markets, need a cost-effective system that has the flexibility to evolve with the demands of its users and accommodate for future growth. Discovery IQ Gen 2 is made for this. It is an accessible, mobile-ready platform designed with a fully-scalable detector ready to meet the clinical needs of places in areas with limited access and tighter financial requirements.

A system designed around you and your patients

The Discovery IQ Gen 2 improvements don’t stop with high-performance software upgrades. Now with a smaller footprint, Discovery IQ Gen 2 also offers hardware enhancements that reduce radiation exposure to technologists and improves the user interface for exam reporting. Combined with the latest software upgrades, this allows for a better technologist and patient experience while enabling a powerful boost in PET/CT productivity and performance.

The next generation is here

Discovery IQ Gen 2 is the next generation of our high-performance PET/CT system thoughtfully engineered with faster scan times, lower dose techniques and the ability to scan patients of all sizes. By combining best-in-class sensitivity with MotionFree image clarity and trusted Q.Clear quantitation, Discovery IQ Gen 2 is the smartest choice for ensuring better outcomes through true discovery.